Aerpio Pharmaceuticals, Inc. Purchase Agreements
3 Contracts & Agreements
- Form of Securities Purchase Agreement, dated September 22, 2022, by and among the Company and the Purchasers (Filed With SEC on September 22, 2022)
- Negotiated Purchase Order Terms and Conditions for Clinical and Commercial Product, dated as of January 13, 2022, by and between the Company and Fresenius Kabi, LLC (Filed With SEC on May 12, 2022)
- Asset Purchase Agreement dated August 17, 2021, by and between Aerpio Pharmaceuticals, Inc. and EyePoint Pharmaceuticals, Inc (Filed With SEC on August 23, 2021)